Back to Newsroom

Symic Bio to Present at the 15​ th​ Annual BIO Investor Forum

SAN FRANCISCO, Oct. 11, 2016 – Symic Bio, a clinical stage biopharmaceutical company developing a new category of therapeutics focused on extracellular matrix biology, today announced that Ken Horne, Chief Executive Officer, will present at the upcoming BIO Investor Forum conference.

Click here to read the full release